Fentanyl: An Addiction to Be Treated Immediately

Medically Reviewed by Dr., Allan E. Sosin, DABIM

Illicit fentanyl presents a radically different level of risk when compared to many other substances that can be abused. Its potency (50 to 100 times more than other opiates) means that very quickly use can spiral out of anyone's control.

How Does This Happen?

Fentanyl dependency begins simply but progresses quickly. When someone first uses fentanyl, it attaches to the specialized part of the brain that reduces pain and changes mood; it floods the system at levels far exceeding a natural level, essentially hijacking the brain's pleasure and reward systems.

The intense impact of this chemical response of the brain explains why physical dependency can develop after just a few uses.

The body immediately starts adapting to this intense experience. After just a few uses, the person needs more fentanyl to feel the same effects because their body has already begun to adjust. This is called "tolerance."

As tolerance increases, the person must take larger amounts just to avoid feeling sick.

Soon, using fentanyl isn't about trying to feel a false "good," but about preventing suffering. The body has changed to the point where it feels normal only when fentanyl is present.

Without it, the person experiences painful withdrawal symptoms like severe muscle aches, vomiting, diarrhea, and intense anxiety.

As the body adapts, users quickly find themselves needing increasingly larger doses to achieve the same effect, accelerating the addiction cycle: take fentanyl, feel temporarily better, need more fentanyl as the effects wear off, take more to avoid withdrawal, repeat.

The amounts needed keep increasing, relationships start suffering, work performance declines, financial problems develop, and health deteriorates. The person finds themselves thinking about fentanyl constantly, prioritizing it above everything else in their life.

The downward spiral of fentanyl abuse can happen remarkably quickly—often within weeks rather than months or years—because of how incredibly strong it is.

By the time many people recognize they have a situation, the dependency has already taken firm hold.

Beyond usage of fentanyl itself, clear warning signs that there is a situation include the following:

• Behavioral shifts: Increased secrecy, neglecting responsibilities, abandoning previously enjoyed activities, and financial problems.

• Mood changes: Alternating between euphoria and severe irritability, anxiety when unable to use, and depression.

• Social changes: Withdrawing from family and friends, changing social circles, and avoiding situations where drug use isn't possible.

• Performance decline: Decreased work or school performance, missing deadlines, and calling in sick frequently.

• Paraphernalia: Finding items such as tin foil with burn marks, straws or tubes for snorting, syringes, or unknown pills.

The presence of any of these signs alongside fentanyl use indicates an urgent need for professional intervention—waiting for "rock bottom" with fentanyl can be fatal, as the margin between a typical dose and a lethal dose is dangerously narrow.

Overcoming fentanyl addiction presents unique challenges due to the long-lasting withdrawal symptoms that can follow opioid dependence.

While the initial withdrawal phase typically lasts 3 to 10 days, opioid dependence can trigger a much longer set of symptoms, with persistent mental and physical symptoms that continue for weeks, months, or in some cases longer after use has stopped.

These long-term withdrawal effects include: intense, unpredictable cravings, mood disturbances, sleep abnormalities, cognitive impairment, and heightened sensitivity to stress, all of which significantly increase relapse risk.

Illicit Fentanyl

 

An aspect to this is fentanyl's use in counterfeit pills: dealers increasingly use this potent synthetic opioid to replace or to mix in with other substances. Counterfeit prescription pills designed to mimic oxycodone, Xanax, and other medications frequently contain doses of fentanyl, while stimulants like methamphetamine and cocaine are routinely contaminated either deliberately or through cross-contamination.

Two milligrams of fentanyl is capable of causing fatal respiratory depression—and with no quality control in illicit manufacturing, users get a potentially lethal result with every encounter.

This is one of many aspects of the alarming rise in overdose deaths among individuals who had no intention of consuming opioids, as many victims were simply seeking substances unaware of the deadly fentanyl hidden within.

Where is it manufactured: Illicit fentanyl is predominantly manufactured in clandestine laboratories using chemicals sourced primarily from China, Mexico, and India, specifically for distribution to illegal drug markets worldwide.

This isn't an example of diverted medical products, where a pharmaceutical-grade substance is somehow found and sold in a non-pharmacy or street setting; these are illicit operations synthesizing fentanyl and its analogs from scratch.

This illicit production has evolved into a global supply chain, with chemical manufacturers, middlemen, and distributors operating across international borders to evade detection.

Mexican cartels have emerged as major producers, using existing trafficking routes to flood North America, while online darknet marketplaces enable another channel of "direct-to-consumer" sales.

The economics are staggering; a kilogram of fentanyl costing approximately $1,000 to produce can generate millions in street value when cut into heroin or pressed into counterfeit pills.

These are among the many reasons why illicit fentanyl is readily available.

What to do?

Find Out

Signs of any fentanyl use outside a specific medical setting are enough information that the situation requires immediate professional attention.

The next question is not: "Will he agree to go to rehab?" A person whose thinking and behavior have been overtaken by addiction may not recognize the severity of what is happening. They may insist that they can stop whenever they want. They may promise to cut back. They may refuse treatment altogether.

You are no longer just handling your loved one. You are dealing with an addiction that has taken control of their behavior.

However, that does not mean the family has no options. A structured intervention is a tool open to families dealing with a loved one suffering from fentanyl abuse.

A properly planned intervention brings the family together with a clear objective: get the person into appropriate treatment. The purpose is not to argue with them about whether they are an addict, or to make them wrong, punish, or accuse.

The intervention is a specific procedure to break through the denial, resistance, and distorted thinking that can keep a person trapped in addiction and present a clear path into treatment.

And finding the right treatment matters. The goal should not simply be to get the fentanyl out of their system. The right treatment needs to address the whole addiction: the physical dependence, the compulsive behavior, the psychological and emotional factors, the consequences to relationships and daily life, and provide the skills necessary to build a life beyond drugs.

Sources:

• “Drug Trafficker Pleads Guilty for Portland Teen’s Deadly Fentanyl Overdose.” KGW, March 5, 2025. https://www.kgw.com/article/news/local/the-story/portland-fentanyl-dealer-guilty-plea-griffin-hoffman-mcdaniel-overdose-death/283-e877945d-9a5a-46eb-9eb8-37692bb4d180

• Substance Abuse and Mental Health Services Administration. Protracted Withdrawal. Substance Abuse Treatment Advisory 9, no. 1 (July 2010). https://library.samhsa.gov/product/protracted-withdrawal/sma10-4554

• Pacific Northwest National Laboratory. “Fentanyl Analogs.” Accessed July 3, 2026. https://www.pnnl.gov/explainer-articles/fentanyl-analogs

• CAS. “Advancing Progress in the Fight Against Fentanyl.” May 10, 2024. https://www.cas.org/resources/cas-insights/advancing-progress-in-the-fight-against-fentanyl

• U.S. Drug Enforcement Administration. “Facts about Fentanyl.” Accessed July 3, 2026. https://www.dea.gov/resources/facts-about-fentanyl

• Westhoff, Ben. “Written Testimony.” Testimony before the U.S.-China Economic and Security Review Commission, Hearing on Exploring the Growing U.S. Reliance on China’s Biotech and Pharmaceutical Products, July 31, 2019. https://www.uscc.gov/sites/default/files/Ben%20Westhoff%20Written%20Testimony.pdf

• Albores-García, Damaris, and Silvia L. Cruz. “Fentanyl and Other New Psychoactive Synthetic Opioids: Challenges to Prevention and Treatment.” Revista de Investigación Clínica 75, no. 3 (2023): 93–104. https://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0034-83762023000300093

• U.S. Drug Enforcement Administration. “One Pill Can Kill.” Accessed July 3, 2026. https://www.dea.gov/onepill

• Burns, Stephen M., Aaron D. Cunningham, and Susruta Majumdar. "Fentanyl: Receptor Pharmacology, Abuse Potential, and Implications for Treatment." Pharmacology & Therapeutics (2020). https://pmc.ncbi.nlm.nih.gov/articles/PMC7233332/

• National Institute on Drug Abuse. Principles of Drug Addiction Treatment: A Research-Based Guide. 3rd ed. Bethesda, MD: National Institute on Drug Abuse, 2018. https://nida.nih.gov/sites/default/files/podat-3rdEd-508.pdf

• Financial Crimes Enforcement Network. Supplemental Advisory on the Procurement of Precursor Chemicals and Manufacturing Equipment Used for the Synthesis of Illicit Fentanyl and Other Synthetic Opioids. FinCEN Advisory FIN-2024-A002, June 20, 2024. https://www.fincen.gov/sites/default/files/advisory/2024-06-20/FinCEN-Supplemental-Advisory-on-Fentanyl-508C.pdf

• U.S. Attorney’s Office, Southern District of Indiana. “Fentanyl FAQs.” U.S. Department of Justice. Accessed July 3, 2026. https://www.justice.gov/usao-sdin/fentanyl-faqs

• Gerstein, Dean R., and Henrick J. Harwood, eds. “The Effectiveness of Treatment.” In Treating Drug Problems, Volume 1. Washington, DC: National Academy Press, 1990. https://www.ncbi.nlm.nih.gov/books/NBK235506/

• Tanz, Lauren J., Andrea Stewart, R. Matt Gladden, Jean Y. Ko, Lauren Owens, and Julie O’Donnell. “Detection of Illegally Manufactured Fentanyls and Carfentanil in Drug Overdose Deaths — United States, 2021–2024.” Morbidity and Mortality Weekly Report 73, no. 48 (December 5, 2024): 1099–1105 https://www.cdc.gov/mmwr/volumes/73/wr/mm7348a2.htm

• Centers for Disease Control and Prevention. “Notes from the Field: Nitazene-Related Deaths — Tennessee, 2019–2021.” Morbidity and Mortality Weekly Report 71, no. 37 (September 16, 2022): 1196–97. https://www.cdc.gov/mmwr/volumes/71/wr/mm7137a5.htm

• U.S. Drug Enforcement Administration. “DEA’s Third Annual National Family Summit on Fentanyl Highlights Progress in Fight to Save Lives.” November 15, 2024. https://www.dea.gov/press-releases/2024/11/15/deas-third-annual-national-family-summit-fentanyl-highlights-progress